Back to News
Market Impact: 0.55

Is Lululemon Athletica a Buy After Its Latest Earnings Report?

Corporate EarningsCorporate Guidance & OutlookConsumer Demand & RetailCompany FundamentalsManagement & GovernanceTax & TariffsProduct LaunchesAnalyst Estimates

Lululemon's Q1 results were mixed: revenue rose 4% to $2.47 billion and EPS of $1.69 beat the $1.67 consensus, but gross margin fell 410 bps to 54.2% and operating income dropped 37% to $276.9 million. More importantly, management cut full-year guidance to $11.0 billion-$11.15 billion in revenue and $10.95-$11.15 EPS, well below expectations, while Q2 outlook also came in far under consensus. Shares fell 11% after hours as weak North American comps, tariffs, and soft product momentum kept the turnaround in doubt.

Analysis

This is less a one-quarter miss than evidence that the core thesis has broken: the brand no longer has enough pricing power in North America to offset traffic deterioration, while the cost base still behaves like a growth retailer. The market is now effectively underwriting a reset cycle rather than a temporary pause, which means earnings risk remains asymmetrically negative for the next 2-3 quarters as inventory, promotions, and SG&A decisions lag the demand reality.

The second-order loser is not just LULU shareholders; it is any premium athleticwear name that relies on the same affluent U.S. consumer and the same “aspirational” product-refresh cadence. If LULU is forced to chase volume with more promotions, it compresses category economics and raises the bar for competitors to hold full-price sell-through. That dynamic should also relieve some pressure on NKE in women’s performance/athleisure if it can keep product novelty and distribution sharper, though Nike’s own turnaround risk means this is more a relative than absolute beneficiary.

The key catalyst is new leadership, but the timing matters: three months is long enough for the stock to re-rate lower if upcoming checks confirm weak traffic, yet too short for a fundamental rebound. The real upside case requires either a faster-than-expected product reset or a cleaner margin inflection from tariff relief / better inventory discipline; absent that, current valuation is cheap for a reason, not a dislocation. The market is likely underestimating how much brand heat has to recover before North America comps stop dragging fixed-cost leverage.

Contrarian view: the setup is bearish, but not uninvestable. With the stock already heavily de-rated, the next leg down likely needs either another guidance reset or evidence that the new CEO will inherit a structurally damaged demand engine, not just a bad quarter. That creates a narrow tactical window where bad news may be less punishable unless the company signals a prolonged promotional response.